Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Mar;57(3):313–316. doi: 10.1038/bjc.1988.69

Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease.

A Alexopoulos 1, W Hutchinson 1, A Bari 1, J J Keating 1, P J Johnson 1, R Williams 1
PMCID: PMC2246512  PMID: 2833301

Abstract

Serum thyroxine was significantly higher in 59 patients with hepatocellular carcinoma than in normal subjects, patients with uncomplicated cirrhosis (48), or other primary tumours with or without hepatic metastases (50). Elevated thyroxine levels appeared attributable to high levels of thyroxine binding globulin which showed a positive linear correlation with serum thyroxine in all groups studied. Despite this hyperthyroxinaemia all patients appeared clinically euthyroid and, consistent with this, T3 was elevated in only one patient and the free thyroxine index was normal in all. Amongst a group of 25 cirrhotic patients who were followed-up for between 12 and 72 months, there was a striking dissociation between the TBG values of those destined to develop HCC and those who did not. In the former group TBG rose steadily with time whereas in the latter group levels remained stable, or, more often, fell. The rises in TBG occurred prior to any clinical signs of tumour development and may be one of the earliest serological changes to occur during carcinogenesis in the cirrhotic liver.

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chopra I. J., Solomon D. H., Chopra U., Young R. T., Chua Teco G. N. Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab. 1974 Sep;39(3):501–511. doi: 10.1210/jcem-39-3-501. [DOI] [PubMed] [Google Scholar]
  2. Gershengorn M. C., Larsen P. R., Robbins J. Radioimmunoassay for serum thyroxine-binding globulin: results in normal subjects and in patients with hepatocellular carcinoma. J Clin Endocrinol Metab. 1976 May;42(5):907–911. doi: 10.1210/jcem-42-5-907. [DOI] [PubMed] [Google Scholar]
  3. Glinoer D., Gershengorn M. C., Dubois A., Robbins J. Stimulation of thyroxine-binding globulin synthesis by isolated rhesus monkey hepatocytes after in vivo beta-estradiol administration. Endocrinology. 1977 Mar;100(3):807–813. doi: 10.1210/endo-100-3-807. [DOI] [PubMed] [Google Scholar]
  4. Glinoer D., Gershengorn M. C., Robbins J. Thyroxine-binding globulin biosynthesis in isolated monkey hepatocytes. Biochim Biophys Acta. 1976 Jan 19;418(2):232–244. doi: 10.1016/0005-2787(76)90073-3. [DOI] [PubMed] [Google Scholar]
  5. Green J. R., Snitcher E. J., Mowat N. A., Ekins R. P., Rees L. H., Dawson A. M. Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities. Clin Endocrinol (Oxf) 1977 Dec;7(6):453–461. doi: 10.1111/j.1365-2265.1977.tb01337.x. [DOI] [PubMed] [Google Scholar]
  6. Gärtner R., Henze R., Horn K., Pickardt C. R., Scriba P. C. Thyroxine-binding globulin: investigation of microheterogeneity. J Clin Endocrinol Metab. 1981 Apr;52(4):657–664. doi: 10.1210/jcem-52-4-657. [DOI] [PubMed] [Google Scholar]
  7. Hepner G. W., Chopra I. J. Serum thyroid hormone levels in patients with liver disease. Arch Intern Med. 1979 Oct;139(10):1117–1120. [PubMed] [Google Scholar]
  8. Kalk W. J., Kew M. C., Danilewitz M. D., Jacks F., van der Walt L. A., Levin J. Thyroxine binding globulin and thyroid function tests in patients with hepatocellular carcinoma. Hepatology. 1982 Jan-Feb;2(1):72–76. doi: 10.1002/hep.1840020112. [DOI] [PubMed] [Google Scholar]
  9. Lumholtz I. B., Faber J., Sørensen M. B., Kirkegaard C., Siersbaek-Nielsen K., Friis T. Peripheral metabolism of T4, T3, reverse T3, 3',5'- diiodothyronine and 3,3' diiodothyronine in liver cirrhosis. Horm Metab Res. 1978 Nov;10(6):566–567. doi: 10.1055/s-0028-1095851. [DOI] [PubMed] [Google Scholar]
  10. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  11. Murata Y., Sarne D. H., Horwitz A. L., Lecocq R., Aden D. P., Knowles B. B., Refetoff S. Characterization of thyroxine-binding globulin secreted by a human hepatoma cell line. J Clin Endocrinol Metab. 1985 Mar;60(3):472–478. doi: 10.1210/jcem-60-3-472. [DOI] [PubMed] [Google Scholar]
  12. Nelson R. B. Thyroxine-binding globulin in hepatoma. Arch Intern Med. 1979 Sep;139(9):1063–1063. [PubMed] [Google Scholar]
  13. Nomura S., Pittman C. S., Chambers J. B., Jr, Buck M. W., Shimizu T. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J Clin Invest. 1975 Sep;56(3):643–652. doi: 10.1172/JCI108134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Takamatsu J., Refetoff S. Inherited heat-stable variant thyroxine-binding globulin (TBG-Chicago). J Clin Endocrinol Metab. 1986 Nov;63(5):1140–1144. doi: 10.1210/jcem-63-5-1140. [DOI] [PubMed] [Google Scholar]
  15. Zaman S. N., Melia W. M., Johnson R. D., Portmann B. C., Johnson P. J., Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet. 1985 Jun 15;1(8442):1357–1360. doi: 10.1016/s0140-6736(85)91785-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES